Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusheng Qu

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 29, 2015
Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA PlatformYusheng Qu, Hugo M Vargas
Pharmacology Research & Perspectives|September 24, 2020
Effects of omecamtiv mecarbil on calcium-transients and contractility in a translational canine myocyte modelBaoXi Gao, Weston Sutherland, Hugo M Vargas, et al.
Journal of Pharmacological and Toxicological Methods|September 6, 2011
hERG potency estimates based upon dose solution analysis: What have we learned?Yusheng Qu, Paul Schnier, Roger Zanon, et al.
Journal of Pharmacological and Toxicological Methods|March 23, 2013
Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delayYusheng Qu, Baoxi Gao, Mei Fang, et al.
Journal of Pharmacological and Toxicological Methods|June 3, 2021
Validation of using cardioplegic solutions for preserving cardiac function in isolated rabbit heart assaysZiva Arimura, BaoXi Gao, Mei Fang, et al.
Clinical and Translational Science|May 6, 2021
Comprehensive in vitro pro-arrhythmic assays demonstrate that omecamtiv mecarbil has low pro-arrhythmic riskYusheng Qu, BaoXi Gao, Ziva Arimura, et al.
Clinical Pharmacology and Therapeutics|February 16, 2024
Scientific Review of the Proarrhythmic Risks of Oligonucleotide Therapeutics: Are Dedicated ICH S7B/E14 Studies Needed for Low-Risk Modalities?Yusheng Qu, Kim A Henderson, Tod A Harper, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 6, 2011
BeKm-1, a peptide inhibitor of human ether-a-go-go-related gene potassium currents, prolongs QTc intervals in isolated rabbit heartYusheng Qu, Mei Fang, Baoxi Gao, et al.
Journal of Pharmacological and Toxicological Methods|July 7, 2020
Inotropic assessment in engineered 3D cardiac tissues using human induced pluripotent stem cell-derived cardiomyocytes in the Biowire<sup>TM</sup> II platformYusheng Qu, Nicole Feric, Isabella Pallotta, et al.
The Journal of Biological Chemistry|May 9, 2006
Structure and function of the voltage sensor of sodium channels probed by a beta-scorpion toxinSandrine Cestèle, Vladimir Yarov-Yarovoy, Yusheng Qu, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 29, 2015
Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA PlatformYusheng Qu, Hugo M Vargas
Pharmacology Research & Perspectives|September 24, 2020
Effects of omecamtiv mecarbil on calcium-transients and contractility in a translational canine myocyte modelBaoXi Gao, Weston Sutherland, Hugo M Vargas, et al.
Journal of Pharmacological and Toxicological Methods|September 6, 2011
hERG potency estimates based upon dose solution analysis: What have we learned?Yusheng Qu, Paul Schnier, Roger Zanon, et al.
Journal of Pharmacological and Toxicological Methods|March 23, 2013
Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delayYusheng Qu, Baoxi Gao, Mei Fang, et al.
Journal of Pharmacological and Toxicological Methods|June 3, 2021
Validation of using cardioplegic solutions for preserving cardiac function in isolated rabbit heart assaysZiva Arimura, BaoXi Gao, Mei Fang, et al.
Clinical and Translational Science|May 6, 2021
Comprehensive in vitro pro-arrhythmic assays demonstrate that omecamtiv mecarbil has low pro-arrhythmic riskYusheng Qu, BaoXi Gao, Ziva Arimura, et al.
Clinical Pharmacology and Therapeutics|February 16, 2024
Scientific Review of the Proarrhythmic Risks of Oligonucleotide Therapeutics: Are Dedicated ICH S7B/E14 Studies Needed for Low-Risk Modalities?Yusheng Qu, Kim A Henderson, Tod A Harper, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 6, 2011
BeKm-1, a peptide inhibitor of human ether-a-go-go-related gene potassium currents, prolongs QTc intervals in isolated rabbit heartYusheng Qu, Mei Fang, Baoxi Gao, et al.
Journal of Pharmacological and Toxicological Methods|July 7, 2020
Inotropic assessment in engineered 3D cardiac tissues using human induced pluripotent stem cell-derived cardiomyocytes in the Biowire<sup>TM</sup> II platformYusheng Qu, Nicole Feric, Isabella Pallotta, et al.
The Journal of Biological Chemistry|May 9, 2006
Structure and function of the voltage sensor of sodium channels probed by a beta-scorpion toxinSandrine Cestèle, Vladimir Yarov-Yarovoy, Yusheng Qu, et al.
Pageof 3